Lotus Eye Hospital Announces Postal Ballot Results with Overwhelming Approval
Lotus Eye Hospital And Institute Limited announced successful completion of its postal ballot process with all three director appointments receiving 99.07% shareholder approval. The e-voting conducted through CDSL platform saw 38 members casting 79,25,006 votes, with Dr S Natesan's reappointment as Independent Director for a second five-year term and Dr KS Ramalingam's continuation and fresh appointment as Non-Executive Director all receiving overwhelming support, demonstrating strong shareholder confidence in the board composition.
*this image is generated using AI for illustrative purposes only.
Lotus Eye Hospital And Institute Limited has successfully concluded its postal ballot process with all three director appointments receiving overwhelming shareholder approval. The company announced the voting results on January 19, 2026, with all resolutions passed by a substantial majority of 99.07%.
Postal Ballot Voting Results
The e-voting process conducted through CDSL platform concluded on January 17, 2026, with strong shareholder participation. The voting results demonstrate unanimous support for the proposed director appointments:
| Parameter: | Details |
|---|---|
| Total Members Voted: | 38 |
| Total Votes Cast: | 79,25,006 |
| Votes in Favor: | 78,50,995 (99.07%) |
| Votes Against: | 74,011 (0.93%) |
| Scrutinizer: | Mr P Eswaramoorthy, Company Secretary (FCS No 6510) |
Director Appointments Approved
All three special resolutions related to director appointments received identical voting results, reflecting strong shareholder confidence in the board composition.
Dr KS Ramalingam Appointments Confirmed
Shareholders approved both resolutions concerning Dr KS Ramalingam's directorship. The first resolution confirmed his continuation as Non-Executive Director from June 1, 2025, to February 8, 2026, while the second approved his fresh appointment from February 9, 2026, with retirement by rotation provisions.
| Parameter: | Details |
|---|---|
| Director Name: | Dr KS Ramalingam |
| DIN: | 01016571 |
| Position: | Non-Executive Director |
| Annual Remuneration: | ₹12.00 lakh |
| Shareholding: | 3,02,804 shares |
Dr S Natesan Reappointed for Second Term
Dr S Natesan's reappointment as Independent Director for a second consecutive five-year term from January 3, 2026, to January 3, 2031, received strong shareholder endorsement.
| Parameter: | Details |
|---|---|
| Director Name: | Dr S Natesan |
| DIN: | 09012904 |
| Position: | Independent Director |
| Term Duration: | 5 years (second consecutive term) |
| Effective Period: | January 3, 2026 to January 3, 2031 |
| Experience: | 50+ years in medicine and hospital administration |
Regulatory Compliance and Process
The postal ballot process was conducted in accordance with Section 110 of the Companies Act, 2013, and Regulation 44 of SEBI LODR 2015. The e-voting facility was exclusively provided through CDSL platform, with the voting period extending from December 19, 2025, to January 17, 2026.
| Process Detail: | Information |
|---|---|
| Notice Date: | December 18, 2025 |
| Cut-off Date: | December 16, 2025 |
| E-voting Period: | December 19, 2025 to January 17, 2026 |
| Results Declaration: | January 19, 2026 |
| Effective Date: | January 17, 2026 |
The scrutinizer's report confirmed the fair and transparent conduct of the voting process, with all electronic data and records handed over to the company for safe keeping. The voting results have been communicated to both BSE and NSE as per regulatory requirements and made available on the company's website at www.lotuseye.org .
Historical Stock Returns for Lotus Eye Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.11% | -4.37% | +0.80% | +69.22% | +85.22% | +244.10% |
20
